Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulations 30 and 33), Gujarat Inject Kerala Limited announced the outcome of its Board Meeting held on Wednesday, 15th July, 2026. The meeting commenced at 09:00 a.m. and concluded at 09:45 a.m. at the Registered Office of the Company.
The Board of Directors discussed, approved, and took on record the following matters:
1. Approved the Un-Audited Standalone Financial Results of the Company for the First Quarter ended on 30th June, 2026.
2. Took on record the 'Limited Review Report' issued by the statutory auditors, M/s. S Mandawat & Co.
Financial Results Highlights (Standalone, Unaudited, ₹ in Lakh)
Quarter Ended 30th June, 2026 (Q1 FY2027)
- Revenue From Operations (Net Sales): ₹1,245.45 Lakh
- Total Income: ₹1,245.45 Lakh (No Other Income reported)
- Expenses:
- Purchases of stock-in-trade: ₹1,068.96 Lakh
- Employee benefit expense: ₹2.90 Lakh
- Finance Costs: ₹0.00 Lakh
- Depreciation and amortisation expense: ₹0.00 Lakh
- Other Expenses: ₹4.83 Lakh
- Total Expenses: ₹1,076.69 Lakh
- Profit before tax: ₹168.76 Lakh
- Tax Expense: ₹43.60 Lakh (Current Tax)
- Profit for the period: ₹125.16 Lakh
- Earnings Per Share (EPS) - Basic and Diluted: ₹0.86
- Paid-up equity share capital: ₹1,463.48 Lakh
- Face value per share: ₹10.00
Comparative Financials
- Quarter Ended 31st March, 2026 (Q4 FY2026 - Audited): Revenue ₹3,069.77 Lakh, Profit ₹163.51 Lakh, EPS ₹1.12
- Quarter Ended 30th June, 2025 (Q1 FY2026 - Unaudited): Revenue ₹242.12 Lakh, Profit ₹7.35 Lakh, EPS ₹0.05
- Year Ended 31st March, 2026 (FY2026 - Audited): Revenue ₹3,632.04 Lakh, Total Income ₹3,651.67 Lakh, Profit ₹181.41 Lakh, EPS ₹1.24
Additional Information
- The financial results are prepared in accordance with Indian Accounting Standards (Ind AS) 34, 'Interim Financial Reporting'.
- The company has only one reportable segment as per Ind AS 108.
- The figures for the corresponding previous period have been restated/regrouped wherever necessary for comparability.
- The results were reviewed by the Audit Committee and subsequently approved by the Board of Directors on July 15, 2026.